ayrshire_blue
Well-Known Member
- Joined
- 1 May 2008
- Messages
- 5,835
I wouldn't worry about it too much.
The results look good.
The endpoint will have been agreed in advance with the regulatory agency (always is for phase 3 trials, not just this one)
Their lawyers and regulatory experts would not have allowed them to make a misleading press release - its illegal under financial law.
There's lots of detail unclear from the press release. This isn't unusual for a phase 3 trial. The trial is complex because it covers multiple countries. Again, not at all unusual.
It's always possible that something surprising and negative will emerge, but I wouldn't lose sleep over it.
Thank you. Good to know this stuff.